Aptose Biosciences Inc (NASDAQ: APTO) is -51.00% lower on its value in year-to-date trading and has touched a low of $0.13 and a high of $1.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The APTO stock was last observed hovering at around $0.14 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.11, the stock is -37.70% and -44.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.39 million and changing -23.23% at the moment leaves the stock -76.73% off its SMA200. APTO registered -93.80% loss for a year compared to 6-month loss of -72.67%.
The stock witnessed a -48.17% gain in the last 1 month and extending the period to 3 months gives it a -59.58%, and is -42.98% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 24.69% over the week and 13.01% over the month.
Aptose Biosciences Inc (APTO) has around 35 employees, a market worth around $6.64M and $0.00M in sales. Distance from 52-week low is -15.08% and -94.31% from its 52-week high. The company has generated returns on investments over the last 12 months (-3057.22%).
The EPS is expected to grow by 76.39% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Aptose Biosciences Inc (APTO) Top Institutional Holders
The shares outstanding are 60.18M, and float is at 56.51M with Short Float at 1.76%.
The top institutional shareholder in the company is DOHENY ASSET MANAGEMENT /CA with over 50550.0 shares valued at $0.32 million. The investor’s holdings represent 0.3849% of the APTO Shares outstanding. As of 2024-06-30, the second largest holder is CALDWELL SUTTER CAPITAL, INC. with 92.0 shares valued at $70.0 to account for 0.0007 of the shares outstanding.
Aptose Biosciences Inc (APTO) Insider Activity
The most recent transaction is an insider purchase by Rice William G., the company’s Chair, President & CEO. SEC filings show that Rice William G. bought 100,000 shares of the company’s common stock on Nov 25 ’24 at a price of $0.20 per share for a total of $20000.0. Following the purchase, the insider now owns 0.61 million shares.
